These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30184181)

  • 1. Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.
    Marrazzo JM; Dombrowski JC; Wierzbicki MR; Perlowski C; Pontius A; Dithmer D; Schwebke J
    Clin Infect Dis; 2019 Feb; 68(5):803-809. PubMed ID: 30184181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana'a city, Yemen.
    Abdul-Aziz M; Mahdy MAK; Abdul-Ghani R; Alhilali NA; Al-Mujahed LKA; Alabsi SA; Al-Shawish FAM; Alsarari NJM; Bamashmos W; Abdulwali SJH; Al Karawani M; Almikhlafy AA
    BMC Infect Dis; 2019 Oct; 19(1):879. PubMed ID: 31640583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis in reproductive-age women in Yunnan, China: a descriptive study.
    Zhao T; Xiao X; Xiao L; Wu XM; Yuan T
    J Obstet Gynaecol; 2022 Oct; 42(7):3187-3192. PubMed ID: 35947028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis.
    Xiao B; A D; Qin H; Mi L; Zhang D
    Front Cell Infect Microbiol; 2022; 12():860589. PubMed ID: 35372135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Associated Factors, and Appropriateness of Empirical Treatment of Trichomoniasis, Bacterial Vaginosis, and Vulvovaginal Candidiasis among Women with Vaginitis.
    Huang SH; Hsu HC; Lee TF; Fan HM; Tseng CW; Chen IH; Shen H; Lee CY; Tai HT; Hsu HM; Hung CC
    Microbiol Spectr; 2023 Jun; 11(3):e0016123. PubMed ID: 37052487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of reliability of self-collected vaginal swabs over physician-collected samples for diagnosis of bacterial vaginosis, candidiasis and trichomoniasis, in a resource-limited setting: a cross-sectional study in India.
    Khan Z; Bhargava A; Mittal P; Bharti R; Puri P; Khunger N; Bala M
    BMJ Open; 2019 Aug; 9(8):e025013. PubMed ID: 31462459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis.
    Liu MB; Xu SR; He Y; Deng GH; Sheng HF; Huang XM; Ouyang CY; Zhou HW
    PLoS One; 2013; 8(11):e79812. PubMed ID: 24265786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.
    Muzny CA; Schwebke JR
    Clin Infect Dis; 2015 Aug; 61(4):601-6. PubMed ID: 25935553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care.
    Barnes P; Vieira R; Harwood J; Chauhan M
    Br J Gen Pract; 2017 Dec; 67(665):e824-e829. PubMed ID: 29158246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome.
    Zhao C; Li Y; Chen B; Yue K; Su Z; Xu J; Xue W; Zhao G; Zhang L
    Microbiol Spectr; 2023 Jun; 11(3):e0315222. PubMed ID: 36995230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of
    Mändar R; Sõerunurk G; Štšepetova J; Smidt I; Rööp T; Kõljalg S; Saare M; Ausmees K; Le DD; Jaagura M; Piiskop S; Tamm H; Salumets A
    Benef Microbes; 2023 Apr; 14(2):143-152. PubMed ID: 36856121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.
    McClelland RS; Balkus JE; Lee J; Anzala O; Kimani J; Schwebke J; Bragg V; Lensing S; Kavak L
    J Infect Dis; 2015 Jun; 211(12):1875-82. PubMed ID: 25526757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis.
    Murina F; Vicariotto F; Di Francesco S
    New Microbiol; 2018 Jul; 41(3):220-224. PubMed ID: 29874389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
    J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
    Chavoustie SE; Carter BA; Waldbaum AS; Donders GGG; Peters KH; Schwebke JR; Paull JRA; Price CF; Castellarnau A; McCloud P; Kinghorn GR
    Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():13-18. PubMed ID: 31812702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.
    Powell A; Ghanem KG; Rogers L; Zinalabedini A; Brotman RM; Zenilman J; Tuddenham S
    Sex Transm Dis; 2019 Dec; 46(12):810-812. PubMed ID: 31663976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.